Stomach Neoplasms [clinicaltrials_resource:42005a00d05c1468cd7a5e21bc52ff69]
Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis [clinicaltrials:NCT00001332]A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab [clinicaltrials:NCT00001805]Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing a Treatment Plan of Preoperative Chemotherapy and Radiation Therapy, Followed by Surgery [clinicaltrials:NCT00036400]Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver [clinicaltrials:NCT00041808]Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer [clinicaltrials:NCT00042510]Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer [clinicaltrials:NCT00054873]Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy [clinicaltrials:NCT00087503]Study of Adjuvant Radiochemotherapy for Gastric Cancer [clinicaltrials:NCT00188266]clinicaltrials:NCT00226811Oxaliplatin in Gastric Cancer [clinicaltrials:NCT00263354]An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer [clinicaltrials:NCT00270543]Early Detection of Esophageal Cancer [clinicaltrials:NCT00341523]Docetaxel in Locally Advanced Gastric Adenocarcinoma [clinicaltrials:NCT00343239]Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction [clinicaltrials:NCT00374985]clinicaltrials:NCT00375999clinicaltrials:NCT00382720Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer [clinicaltrials:NCT00384878]clinicaltrials:NCT00390416Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer [clinicaltrials:NCT00411229]Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas [clinicaltrials:NCT00419627]Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer [clinicaltrials:NCT00420394]clinicaltrials:NCT00447330clinicaltrials:NCT00454519Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway [clinicaltrials:NCT00498134]Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric Cancer [clinicaltrials:NCT00511446]A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer [clinicaltrials:NCT00512681]clinicaltrials:NCT00515190clinicaltrials:NCT00515216clinicaltrials:NCT00525005Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal Seeding [clinicaltrials:NCT00539877]clinicaltrials:NCT00553696clinicaltrials:NCT00555620clinicaltrials:NCT00555672Perioperative Nutrition in Upper Gastrointestinal (GI) Cancer Surgery [clinicaltrials:NCT00560846]Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample [clinicaltrials:NCT00568438]S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer [clinicaltrials:NCT00580359]Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer [clinicaltrials:NCT00587145]clinicaltrials:NCT00591045A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer [clinicaltrials:NCT00611507]huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas [clinicaltrials:NCT00620607]
condition [clinicaltrials_vocabulary:condition]
Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis [clinicaltrials:NCT00001332]A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab [clinicaltrials:NCT00001805]Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer [clinicaltrials:NCT00002615]High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer [clinicaltrials:NCT00002722]Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer [clinicaltrials:NCT00002783]Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus [clinicaltrials:NCT00002883]clinicaltrials:NCT00003046Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer [clinicaltrials:NCT00003055]Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors [clinicaltrials:NCT00003125]clinicaltrials:NCT00003137clinicaltrials:NCT00003157Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer [clinicaltrials:NCT00003172]clinicaltrials:NCT00003192Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach [clinicaltrials:NCT00003237]clinicaltrials:NCT00003298Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer [clinicaltrials:NCT00003427]Antineoplaston Therapy in Treating Patients With Stomach Cancer [clinicaltrials:NCT00003524]Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach [clinicaltrials:NCT00003617]clinicaltrials:NCT00003748Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer [clinicaltrials:NCT00003862]Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer [clinicaltrials:NCT00004065]Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer [clinicaltrials:NCT00004099]Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer [clinicaltrials:NCT00004103]clinicaltrials:NCT00004127clinicaltrials:NCT00004233clinicaltrials:NCT00004235Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer [clinicaltrials:NCT00004236]clinicaltrials:NCT00004604Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer [clinicaltrials:NCT00004873]Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery [clinicaltrials:NCT00004895]Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction [clinicaltrials:NCT00004910]Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction [clinicaltrials:NCT00004911]Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer [clinicaltrials:NCT00005049]Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer [clinicaltrials:NCT00005060]Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer [clinicaltrials:NCT00005599]Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus [clinicaltrials:NCT00005607]Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer [clinicaltrials:NCT00005638]Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery [clinicaltrials:NCT00005876]Biological Therapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00005956]
condition browse [clinicaltrials_vocabulary:condition-browse]
Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis [clinicaltrials:NCT00001332]A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab [clinicaltrials:NCT00001805]Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer [clinicaltrials:NCT00002615]High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer [clinicaltrials:NCT00002722]Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer [clinicaltrials:NCT00002783]Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus [clinicaltrials:NCT00002883]clinicaltrials:NCT00003046Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer [clinicaltrials:NCT00003055]Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors [clinicaltrials:NCT00003125]clinicaltrials:NCT00003137clinicaltrials:NCT00003157Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer [clinicaltrials:NCT00003172]clinicaltrials:NCT00003192Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach [clinicaltrials:NCT00003237]clinicaltrials:NCT00003298Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer [clinicaltrials:NCT00003427]Antineoplaston Therapy in Treating Patients With Stomach Cancer [clinicaltrials:NCT00003524]Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach [clinicaltrials:NCT00003617]clinicaltrials:NCT00003748Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer [clinicaltrials:NCT00003862]Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer [clinicaltrials:NCT00004065]Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer [clinicaltrials:NCT00004099]Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer [clinicaltrials:NCT00004103]clinicaltrials:NCT00004127clinicaltrials:NCT00004233clinicaltrials:NCT00004235Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer [clinicaltrials:NCT00004236]clinicaltrials:NCT00004604Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer [clinicaltrials:NCT00004873]Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery [clinicaltrials:NCT00004895]Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction [clinicaltrials:NCT00004910]Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction [clinicaltrials:NCT00004911]Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer [clinicaltrials:NCT00005049]Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer [clinicaltrials:NCT00005060]Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer [clinicaltrials:NCT00005599]Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus [clinicaltrials:NCT00005607]Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer [clinicaltrials:NCT00005638]Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery [clinicaltrials:NCT00005876]Biological Therapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00005956]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Stomach Neoplasms [clinicaltrials_resource:42005a00d05c1468cd7a5e21bc52ff69]
Bio2RDF identifier
42005a00d05c1468cd7a5e21bc52ff69
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:42005a00d05c1468cd7a5e21bc52ff69
identifier
clinicaltrials_resource:42005a00d05c1468cd7a5e21bc52ff69
title
Stomach Neoplasms
@en
type
label
Stomach Neoplasms [clinicaltrials_resource:42005a00d05c1468cd7a5e21bc52ff69]
@en
Stomach Neoplasms